Acumen Pharmaceuticals In... (ABOS)
NASDAQ: ABOS
· Real-Time Price · USD
1.73
-0.04 (-2.26%)
At close: Oct 03, 2025, 3:59 PM
1.77
2.31%
After-hours: Oct 03, 2025, 06:27 PM EDT
-2.26% (1D)
| Bid | 1.7 |
| Market Cap | 104.79M |
| Revenue (ttm) | 178K |
| Net Income (ttm) | -136.66M |
| EPS (ttm) | -2.8 |
| PE Ratio (ttm) | -0.62 |
| Forward PE | -1.06 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.77 |
| Volume | 373,468 |
| Avg. Volume (20D) | 386,100 |
| Open | 1.79 |
| Previous Close | 1.77 |
| Day's Range | 1.71 - 1.80 |
| 52-Week Range | 0.85 - 3.36 |
| Beta | 0.20 |
| Ex-Dividend Date | n/a |
About ABOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-11.27%
Acumen Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call TranscriptAcumen Pharmaceuticals, Inc. (NASDAQ:ABOS ) Q2 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Alex Braun - VP & Head of Investor Relations Daniel J. O'Connell - CEO & Di...
